AstraZeneca partners with IMS Health

IMS Health will provide AstraZeneca plc (LSE:AZN; NYSE:AZN) access to health outcomes data in Europe under a three-year partnership announced Wednesday. AstraZeneca will use the data, which includes clinical outcome, economic and treatment records, to aid its pipeline discovery and clinical development. The pharma said it hopes the data will help clarify the effect of its medicines beyond what is seen in clinical trials. Financial details were not disclosed. ...